These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 3063494)
21. [Evaluation of the in vitro activity of enoxacin on bacterial strains recently isolated in a hospital milieu]. Lembo M; Nani E; Covelli I; Amato G; Lavitola A G Batteriol Virol Immunol; 1985; 78(7-12):205-16. PubMed ID: 3870425 [TBL] [Abstract][Full Text] [Related]
22. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin. Traub WH Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026 [TBL] [Abstract][Full Text] [Related]
23. Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential. Brogden RN; Campoli-Richards DM Drugs; 1989 Oct; 38(4):524-50. PubMed ID: 2684593 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin. Azadian BS; Talboys CA; Roberts AP J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357 [No Abstract] [Full Text] [Related]
26. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Patel SS; Balfour JA; Bryson HM Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664 [TBL] [Abstract][Full Text] [Related]
27. The role of the fluoroquinolones. Guay DR Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503 [TBL] [Abstract][Full Text] [Related]
29. The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin. Muranaka K; Greenwood D J Antimicrob Chemother; 1988 May; 21(5):545-54. PubMed ID: 3134318 [TBL] [Abstract][Full Text] [Related]
30. Enoxacin for the treatment of urinary tract infection. Bailey RR; Peddie BA N Z Med J; 1985 Apr; 98(777):286-8. PubMed ID: 3857511 [TBL] [Abstract][Full Text] [Related]
31. Tissue penetration and clinical efficacy of enoxacin in respiratory tract infections. Wood MJ Clin Pharmacokinet; 1989; 16 Suppl 1():38-45. PubMed ID: 2653694 [TBL] [Abstract][Full Text] [Related]
35. Intravenous enoxacin for the treatment of acute pyelonephritis: pharmacokinetic and clinical study. Bailey RR; Walker RJ; Lynn KL; Donaldson IM; Peddie BA; Dobbs BR Br J Clin Pharmacol; 1988 Feb; 25(2):223-8. PubMed ID: 3162809 [TBL] [Abstract][Full Text] [Related]
36. Enoxacin treatment of urinary tract infections in elderly patients. Huttunen M; Kunnas K; Saloranta P J Antimicrob Chemother; 1988 Feb; 21 Suppl B():105-11. PubMed ID: 3162900 [TBL] [Abstract][Full Text] [Related]
37. Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections. Onrust SV; Lamb HM; Balfour JA Drugs; 1998 Nov; 56(5):895-928. PubMed ID: 9829160 [TBL] [Abstract][Full Text] [Related]
38. [The effectiveness of enoxacin for the treatment of complicated urinary tract infection]. Germinario C; Quarto M; Viggiani N; Schena FP Riv Eur Sci Med Farmacol; 1992; 14(5):347-51. PubMed ID: 1308966 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule. Wise R; Griggs D; Andrews JM Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327 [TBL] [Abstract][Full Text] [Related]
40. [Comparison of fluoroquinolones (norfloxacin, enoxacin, ofloxacin) in the therapy of lower urinary tract infections]. Tizzani A; Casetta G; Cavallini A; Piana P Minerva Urol Nefrol; 1990; 42(2):81-4. PubMed ID: 2392745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]